Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410486 · ClinicalTrials.gov registry record
Early-Onset Sepsis an NICHD/CDC Surveillance Study
A clinical trial, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- 570
- Enrollment target
NCT02410486: Completed study, sponsored by NICHD Neonatal Research Network.
NCT02410486 is a clinical trial that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 570 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02410486 has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- 570 participants
- Enrollment target
Study Summary
This prospective surveillance study will be conducted over a 2 year period to determine current rates of Early-Onset Sepsis (EOS)/ Early-Onset Meningitis (EOM), associated pathogens, antimicrobial resistance, signs and symptoms and infant outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 570 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-12 |
What the finished NCT02410486 record still lists
NCT02410486 is an observational study that tracks outcomes without assigning an intervention. The registered 570 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02410486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02410486 about?
NCT02410486 is a clinical study titled "Early-Onset Sepsis an NICHD/CDC Surveillance Study". This prospective surveillance study will be conducted over a 2 year period to determine current rates of Early-Onset Sepsis (EOS)/ Early-Onset Meningitis (EOM), associated pathogens, antimicrobial resistance, signs and symptoms and infant outcomes.
What is the current status of trial NCT02410486?
This trial is currently completed. The enrollment target is 570 participants. The study started on 2015-04. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02410486?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia